Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,311) with videos related to
Page
of 132
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trial
Rosanna K Jackson, Martina Liebich, Philip Berry, et al.
Journal of Neurotrauma
|
April 1, 2011
Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury
Robert H Garman, Larry W Jenkins, Robert C Switzer, et al.
JCI Insight
|
March 24, 2025
Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced immunosuppression
Katarina Halpin-Veszeleiova, Michael P Mallouh, Lucy M Williamson, et al.
Genes & Development
|
July 17, 2025
A genome-wide, CRISPR-based screen reveals new requirements for translation initiation and ubiquitination in driving adipogenic fate change
Rachel E Turn, Keren I Hilgendorf, Carl T Johnson, et al.
Molecular Cancer Therapeutics
|
July 23, 2013
Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900
Elizabeth Blackwood, Jennifer Epler, Ivana Yen, et al.
Cell Stem Cell
|
January 25, 2022
Multi-omic analysis reveals divergent molecular events in scarring and regenerative wound healing
Shamik Mascharak, Heather E Talbott, Michael Januszyk, et al.
Bjpsych Open
|
July 5, 2023
Air quality and mental health: evidence, challenges and future directions
Kamaldeep Bhui, Joanne B Newbury, Rachel M Latham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 13, 2012
A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer
Andrew Weickhardt, Robert Doebele, Ana Oton, et al.
Science Translational Medicine
|
March 6, 2015
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M Hatfield, Jorgen Kjaergaard, Dmitriy Lukashev, et al.
Biomarker Insights
|
July 7, 2009
Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice
Birong Liao, Eileen McCall, Karen Cox, et al.
Page
of 132
Search research articles
Search
Showing results (1241-1250 of 1,311) with videos related to
Sort By:
Page
of 132
European Journal of Cancer (Oxford, England : 1990)
|
September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trial
Rosanna K Jackson, Martina Liebich, Philip Berry, et al.
Journal of Neurotrauma
|
April 1, 2011
Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury
Robert H Garman, Larry W Jenkins, Robert C Switzer, et al.
JCI Insight
|
March 24, 2025
Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced immunosuppression
Katarina Halpin-Veszeleiova, Michael P Mallouh, Lucy M Williamson, et al.
Genes & Development
|
July 17, 2025
A genome-wide, CRISPR-based screen reveals new requirements for translation initiation and ubiquitination in driving adipogenic fate change
Rachel E Turn, Keren I Hilgendorf, Carl T Johnson, et al.
Molecular Cancer Therapeutics
|
July 23, 2013
Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900
Elizabeth Blackwood, Jennifer Epler, Ivana Yen, et al.
Cell Stem Cell
|
January 25, 2022
Multi-omic analysis reveals divergent molecular events in scarring and regenerative wound healing
Shamik Mascharak, Heather E Talbott, Michael Januszyk, et al.
Bjpsych Open
|
July 5, 2023
Air quality and mental health: evidence, challenges and future directions
Kamaldeep Bhui, Joanne B Newbury, Rachel M Latham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 13, 2012
A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer
Andrew Weickhardt, Robert Doebele, Ana Oton, et al.
Science Translational Medicine
|
March 6, 2015
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M Hatfield, Jorgen Kjaergaard, Dmitriy Lukashev, et al.
Biomarker Insights
|
July 7, 2009
Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice
Birong Liao, Eileen McCall, Karen Cox, et al.
Page
of 132